In the Glioma/Glioblastoma cancer, 67% (16/24) of tumors exhibited one disease-related variant, of which 94% (15/16) were in IDH1 and 6% (1/16) were in PIK3CA. This evidence concerns the gene IDH1 and central nervous system cancer.